Amgen (AMGN) announced that the FDA has granted accelerated approval to tarlatamab for pre-treated advanced small cell lung cancer (ES-SCLC).Tarlatamab is a delta-like ligand 3 targeting Bispecific T-cell Engager (BiTE) therapy, approved by the name of Imdelltra to treat ES-SCLC patients whose disease has progressed on or after treatment with platinum-based chemotherapy.The approval comes a month ahead of the PDUFA date on Jun 12. With the approval, Imdelltra becomes the first DLL3-targeting BiTE therapy th ...

Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor IMDELLTRA Demonstrated Impressive 40% Objective Response Rate, 9.7 Month Median Duration of Response and 14.3 Month Median Overall Survival in Pivotal DeLLphi-301 Study Amgen to Host Webcast Investor Call on May 20, 2024 at 1:00 p.m. PT THOUSAND OAKS, Calif., May 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult ...

flying white dove isolated on black backgroundgettyRemember when the Federal Reserve stopped printing money for a few months? It didn’t go well.Yes, I’m making fun. A bit. Chairman Jay Powell did abstain from his printing press for nine full months.The year, as you’ll recall, was 2022. Headline inflation topped 8%. Eight! Jay, who had been blaming every supply chain from here to Shanghai for the price pressures, ran out of excuses. He held down the power button on his money printer for a hard reset.Stocks s ...

THOUSAND OAKS, Calif., May 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS) International Conference on May 19 and 20, 2024. The presentation will also include an overview of additional programs from Amgen's innovative inflammation portfolio. Jay Bradner, executive vice presiden ...

Amgen Inc. (NASDAQ:AMGN) BofA Securities 2024 Health Care Conference May 14, 2024 ET Company Participants Peter Griffith - EVP & CFO James Bradner - EVP, Research and Development & Chief Scientific Officer Justin Claeys - VP, IR Conference Call Participants Geoff Meacham - BofA Securities Peter Griffith [Call Starts Abruptly] for the Phase II study is complete and that we are confident in MariTide's differentiated profile and are actively planning a broad Phase 3 program, including obesity, obesity-related ...

17 November 2023, Berlin: View of a screen with the lettering Lilly Deutschland GmbHì. The US ... [+] pharmaceutical company Eli Lilly announced investment plans in Germany at the press conference. Photo: Hannes P. Albert/dpa (Photo by Hannes P Albert/picture alliance via Getty Images)dpa/picture alliance via Getty ImagesGiven its better prospects, we believe Eli Lilly stock (NYSE: LLY) is a better pick than Amgen stock (NASDAQ NASDAQ : AMGN). Both stocks have been in the limelight lately, given their focus ...

The biotech's pipeline extends far beyond this exciting weight-loss product.It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now -- thanks to its now-famous therapy, Wegovy. However, several companies have promising pipeline candidates they hope will eventually challenge Wegovy.One of them is Amgen (AMGN -0.87%), one of the largest biotechs in the world. Amgen recent ...

During this earnings season, Wall Street investors have been paying attention to stocks generating buzz in different sectors. Diversifying investments across the 11 sectors within the S&P 500 index could help weather short-term market volatility. Over the past 12 months, the best performing sector has been information technology, returning well over 30%. Consumer discretionary sector with nearly 20% follows it, and the health care sector holds over 6%. By comparison, the S&P 500 index, which represents the ...

GERMANY - 2024/04/03: In this photo illustration, an Amgen Inc. (formerly Applied Molecular Genetics ... [+] Inc.) logo seen displayed on a tablet. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesAmgen stock (NASDAQ NASDAQ : AMGN) has seen a solid 9% rise in a week, outperforming the broader S&P500 index, up 1.5%. The recent rise can be attributed to the progress with its weight-loss drug — MariTide and its upbeat Q1 results reported las ...

Picking income stocks can be challenging. Some companies pay dividends only to cut them in the future, and others are more focused on stock buybacks instead of dividends. However, research has shown that dividends provide investors with about 35% of their total returns over time. It varies year to year, but holding solid income stocks that consistently raise their annual payout has proven successful.The three dividend stocks to buy below have prioritized returning cash to shareholders and all have excellent ...